Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice

Immunology and Microbiology

• Experimental Autoimmune Myasthenia Gravis 100%
• Mouse 50%
• C57BL 6 Mouse 33%
• Monospecific Antibody 33%
• Interferon Type I 33%
• Knockout Mouse 16%
• Interferon Production 16%
• Interleukin 12 16%
• Isotype 16%
• Nicotinic Acetylcholine Receptor 16%
• Gene Knockout 16%
• Muscle Tissue 16%
• Dose 16%

Medicine and Dentistry

• Experimental Autoimmune Myasthenia Gravis 100%
• Diseases 50%
• Antibody 33%
• Interferon 33%
• Cytokine 16%
• C57BL/6 16%
• Nicotinic Receptor 16%
• Interleukin 12 16%
• Interferon Production 16%
• Gene Knockout 16%
• Muscle Tissue 16%

Neuroscience

• Antibodies 33%
• Interferon 33%
• Cholinergic Receptor 16%
• Interleukin 12 16%
• Nicotinic Acetylcholine Receptor 16%
• Gene Knockout 16%
• Interferon Production 16%